Cinara Carneiro Neves1, Verônica Indicatti Fiamenghi1, Patricia Scolari Fontela2, Jefferson Pedro Piva3. 1. Hospital de Clínicas de Porto Alegre, Pediatric Intensive Care Unit - Porto Alegre (RS), Brazil. 2. McGill University, Department of Pediatrics, Division of Pediatric Critical Care - Montreal (QC), Canada. 3. Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Pediatric Intensive Care Unit - Porto Alegre (RS), Brazil.
Abstract
OBJECTIVE: This study aimed to assess the clonidine infusion rate in the first 6 h, as maintenance dose (first 24 h), and in the pre-extubation period (last 24 h), as well as the cumulative dose of other sedatives and the hemodynamic response. METHODS: This is a retrospective cohort study. RESULTS: Children up to the age of 2 years who were admitted to the pediatric intensive care unit of a tertiary referral hospital in the south region of Brazil, between January 2017 and December 2018, were submitted to mechanical ventilation, and received continuous clonidine infusions were included in the study. The initial, maintenance, and pre-extubation doses of clonidine; the vasoactive-inotropic score; heart rate; and systolic and diastolic blood pressure of the study participants were assessed. A total of 66 patients with a median age of 4 months who were receiving clonidine infusions were included. The main indications for mechanical ventilation were acute viral bronchiolitis (56%) and pneumonia associated with acute respiratory distress syndrome (15%). The median of clonidine infusion in the first 6 h (66 patients) was 0.53 μg/kg/h (IQR 0.49-0.88), followed by 0.85 μg/kg/h (IQR 0.53-1.03) during maintenance (57 patients) and 0.63 μg/kg/h (IQR 0.54-1.01) during extubation period (42 patients) (p=0.03). No differences were observed in the doses regarding the indication for mechanical ventilation. Clonidine infusion was not associated with hemodynamic changes and showed no differences when associated with adjuvants. CONCLUSION: Clonidine demonstrated to be a well-tolerated sedation option in pediatric patients submitted to mechanical ventilation, without relevant influence in hemodynamic variables.
OBJECTIVE: This study aimed to assess the clonidine infusion rate in the first 6 h, as maintenance dose (first 24 h), and in the pre-extubation period (last 24 h), as well as the cumulative dose of other sedatives and the hemodynamic response. METHODS: This is a retrospective cohort study. RESULTS: Children up to the age of 2 years who were admitted to the pediatric intensive care unit of a tertiary referral hospital in the south region of Brazil, between January 2017 and December 2018, were submitted to mechanical ventilation, and received continuous clonidine infusions were included in the study. The initial, maintenance, and pre-extubation doses of clonidine; the vasoactive-inotropic score; heart rate; and systolic and diastolic blood pressure of the study participants were assessed. A total of 66 patients with a median age of 4 months who were receiving clonidine infusions were included. The main indications for mechanical ventilation were acute viral bronchiolitis (56%) and pneumonia associated with acute respiratory distress syndrome (15%). The median of clonidine infusion in the first 6 h (66 patients) was 0.53 μg/kg/h (IQR 0.49-0.88), followed by 0.85 μg/kg/h (IQR 0.53-1.03) during maintenance (57 patients) and 0.63 μg/kg/h (IQR 0.54-1.01) during extubation period (42 patients) (p=0.03). No differences were observed in the doses regarding the indication for mechanical ventilation. Clonidine infusion was not associated with hemodynamic changes and showed no differences when associated with adjuvants. CONCLUSION: Clonidine demonstrated to be a well-tolerated sedation option in pediatric patients submitted to mechanical ventilation, without relevant influence in hemodynamic variables.
Authors: Niina Kleiber; Saskia N de Wildt; Gérard Cortina; Michael Clifford; Thierry Ducruet; Dick Tibboel; Johnny Millar Journal: Pediatr Crit Care Med Date: 2016-04 Impact factor: 3.624
Authors: Christoph Hünseler; Gunter Balling; Christoph Röhlig; Rainer Blickheuser; Uwe Trieschmann; Ulla Lieser; Christian Dohna-Schwake; Corinna Gebauer; Oliver Möller; Fritz Hering; Thomas Hoehn; Stephan Schubert; Roland Hentschel; Ralf G Huth; Andreas Müller; Carsten Müller; Gernot Wassmer; Moritz Hahn; Urs Harnischmacher; Julie Behr; Bernhard Roth Journal: Pediatr Crit Care Med Date: 2014-07 Impact factor: 3.624
Authors: David J Gagnon; Richard R Riker; Elizabeth K Glisic; Andrew Kelner; Hilary M Perrey; Gilles L Fraser Journal: Pharmacotherapy Date: 2015-03 Impact factor: 4.705
Authors: John C Hayden; Cormac Breatnach; Dermot R Doherty; Martina Healy; Moninne M Howlett; Paul J Gallagher; Gráinne Cousins Journal: Pediatr Crit Care Med Date: 2016-02 Impact factor: 3.624
Authors: Amanda M McIntosh; Suhong Tong; Sara J Deakyne; Jesse A Davidson; Halden F Scott Journal: Pediatr Crit Care Med Date: 2017-08 Impact factor: 3.624
Authors: Antje Neubert; Manuel Alberto Baarslag; Monique van Dijk; Joost van Rosmalen; Joseph F Standing; Yucheng Sheng; Wolfgang Rascher; Deborah Roberts; Jackie Winslade; Louise Rawcliffe; Sara M Hanning; Tuuli Metsvaht; Viviana Giannuzzi; Peter Larsson; Pavla Pokorná; Alessandra Simonetti; Dick Tibboel Journal: BMJ Open Date: 2017-06-21 Impact factor: 2.692